A naukri.com initiative
Medium
1d
81
Image Credit: Medium
Exosome Diagnostics and Therapeutics Market Dynamics, Growth, Opportunities and Forecast by 2031
- The exosome diagnostics and therapeutics market is growing based on innovations in exosome separation and characterization techniques.
- Exosomes are important biomarkers for diagnosing various diseases such as cancer and neurodegenerative disorders.
- Exosomes can be isolated from bodily fluids and can serve as a non-invasive 'liquid biopsy.'
- Exosomes can be used for drug delivery, immunotherapy, and regenerative medicine to support tissue repair and regeneration.
- The market is expected to reach US$ 1542.45 Mn by 2031, with a CAGR of 35.1% until 2031.
- Key players in the exosome diagnostics and therapeutics market include Aethlon Medical, Inc, Therapeutic Solutions International, Inc, ReNeuron Group plc, and Immune Therapy Holdings AB.
- Challenges in the market include standardization and regulation of exosome-based tests.
- Opportunities in the market include designing new technologies for exosome separation and analysis, developing exosomes to target select cells, and utilizing AI for exosome analysis.
- Overall, exosomes show potential in revolutionizing diagnostics and therapeutics, though further research and development is required.
- The market will continue to be driven by advancements in exosome research and technology as well as increased investment in personalized medicine.
Read Full Article
4 Likes
For uninterrupted reading, download the app